Cornell Scientific Instruments Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 28-06-2024
- Paid Up Capital ₹ 0.10 M
as on 28-06-2024
- Company Age 11 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 104.27%
(FY 2023)
- Profit 382.74%
(FY 2023)
- Ebitda 2127.71%
(FY 2023)
- Net Worth 28.42%
(FY 2023)
- Total Assets 162.02%
(FY 2023)
About Cornell Scientific Instruments
The Corporate was formerly known as Seryo Pharma Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Deepak Gunwant, Sanjay Devrani, and Sudhir Sharma serve as directors at the Company.
- CIN/LLPIN
U74140DL2013PTC248676
- Company No.
248676
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Feb 2013
- Date of AGM
28 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
West Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Cornell Scientific Instruments?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Devrani  | Director | 06-Sep-2016 | Current |
| Deepak Gunwant | Director | 21-Aug-2019 | Current |
| Sudhir Sharma | Director | 21-Feb-2013 | Current |
Financial Performance of Cornell Scientific Instruments.
Cornell Scientific Instruments Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 104.27% increase. The company also saw a substantial improvement in profitability, with a 382.74% increase in profit. The company's net worth Soared by an impressive increase of 28.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cornell Scientific Instruments?
Unlock access to Cornell Scientific Instruments's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cornell Scientific Instruments?
Unlock and access historical data on people associated with Cornell Scientific Instruments, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cornell Scientific Instruments, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cornell Scientific Instruments's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
